Intrinsiqq
Passage Bio Inc. logo

Passage Bio Inc. Insider Trading

PASG

Compare
Last 12 months

Insiders sold 113K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. President and CEO William Chou sold 75K on Jan 8, 38% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2022.

Net open-market
−113K
0 buys · 2 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
Mar 2022
Mar 21, 2022

Get an email when PASG's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 25
    Weston Nichols
    Large holder · bought 50,055 at $4.12
    206K
    8.0% of stake
  • Jan 8No plan
    Kathleen Borthwick
    CFO · sold 2,062 at $18.44
    38K
    28% of stake
  • Jan 8No plan
    William Chou
    President and CEO · sold 4,076 at $18.44
    75K
    38% of stake
  • Sep 11, 2025 – Sep 15, 2025
    Weston Nichols
    Large holder · bought 32,008 at avg $6.99
    224K
    2.7% of stake
  • Jul 22, 2025 – Jul 24, 2025
    Lynx1 Capital Management LP
    Large holder · bought 128,848 at avg $5.69
    734K
    14% of stake
  • Jun 24, 2025 – Jun 26, 2025No plan
    Orbimed Advisors LLC
    Large holder · sold 583,657 at avg $0.34
    197K
    8.8% of stake
  • Apr 22, 2025 – Apr 24, 2025No plan
    Orbimed Advisors LLC
    Large holder · sold 235,572 at avg $0.33
    79K
    3.4% of stake
  • Apr 15, 2025 – Apr 17, 2025No plan
    Orbimed Capital GP VII LLC
    Large holder · sold 149,054 at avg $0.33
    50K
    2.1% of stake
  • Feb 11, 2025No plan
    Kathleen Borthwick
    CFO · sold 3,183 at $0.53
    2K
    7.2% of stake
  • Jan 10, 2025 – Jan 14, 2025No plan
    Orbimed Advisors LLC
    Large holder · sold 223,219 at avg $0.64
    142K
    3.1% of stake
  • Jan 6, 2025 – Jan 8, 2025No plan
    Orbimed Capital GP VII LLC
    Large holder · sold 147,024 at avg $0.70
    103K
    2.0% of stake
  • Dec 27, 2024
    Lynx1 Capital Management LP
    Large holder · bought 373,645 at $0.65
    243K
    4.2% of stake
  • Dec 20, 2024No plan
    Orbimed Capital GP VII LLC
    Large holder · sold 230,321 at $0.60
    138K
    3.0% of stake
  • Dec 9, 2024 – Dec 11, 2024No plan
    Orbimed Advisors LLC
    Large holder · sold 62,276 at avg $0.83
    52K
    0.8% of stake
  • Dec 4, 2024 – Dec 6, 2024No plan
    Orbimed Capital GP VII LLC
    Large holder · sold 97,103 at avg $0.80
    77K
    1.2% of stake
  • Nov 25, 2024 – Nov 27, 2024
    Lynx1 Capital Management LP
    Large holder · bought 456,353 at avg $0.62
    284K
    2.7% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PASG, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with PASG

CompareIntrinsic value
CGEMCullinan Therapeutics, Inc.
$8.89-1.98%10
PLXProtalix Biotherapeutics Inc.
$2.90-5.23%88
HUMAHumacyte, Inc.
$0.45-17.97%0
BDTXBlack Diamond Therapeutics, Inc.
$1.31-5.76%10
IMCRImmunocore Holdings plc
$26.41-0.83%40
NVAXNovavax Inc.
$7.47-3.24%25
MAZEMaze Therapeutics Inc.
$31.37-3.27%10
ARTVArtiva Biotherapeutics Inc.
$3.78-1.31%10

Spot a number that looks wrong? Check it in PASG's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PASG

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.